- Home
- EVN vs ARCT Comparison
EVN vs ARCT Comparison
Compare EVN & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVN
- ARCT
- Stock Information
- Founded
- EVN 1998
- ARCT 2013
- Country
- EVN United States
- ARCT United States
- Employees
- EVN N/A
- ARCT N/A
- Industry
- EVN Investment Bankers/Brokers/Service
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- EVN Finance
- ARCT Health Care
- Exchange
- EVN Nasdaq
- ARCT Nasdaq
- Market Cap
- EVN 444.3M
- ARCT 526.5M
- IPO Year
- EVN N/A
- ARCT N/A
- Fundamental
- Price
- EVN $10.89
- ARCT $6.76
- Analyst Decision
- EVN
- ARCT Buy
- Analyst Count
- EVN 0
- ARCT 11
- Target Price
- EVN N/A
- ARCT $38.67
- AVG Volume (30 Days)
- EVN 101.2K
- ARCT 971.8K
- Earning Date
- EVN 01-01-0001
- ARCT 11-10-2025
- Dividend Yield
- EVN 4.78%
- ARCT N/A
- EPS Growth
- EVN N/A
- ARCT N/A
- EPS
- EVN 0.34
- ARCT N/A
- Revenue
- EVN N/A
- ARCT $97,601,000.00
- Revenue This Year
- EVN N/A
- ARCT N/A
- Revenue Next Year
- EVN N/A
- ARCT $26.81
- P/E Ratio
- EVN $29.94
- ARCT N/A
- Revenue Growth
- EVN N/A
- ARCT N/A
- 52 Week Low
- EVN $8.64
- ARCT $5.85
- 52 Week High
- EVN $10.45
- ARCT $24.17
- Technical
- Relative Strength Index (RSI)
- EVN 44.22
- ARCT 30.94
- Support Level
- EVN $10.75
- ARCT $5.85
- Resistance Level
- EVN $11.00
- ARCT $6.49
- Average True Range (ATR)
- EVN 0.09
- ARCT 0.47
- MACD
- EVN -0.01
- ARCT 0.32
- Stochastic Oscillator
- EVN 32.96
- ARCT 26.16
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.